MetaCap

Q/C Technologies Earnings

NASDAQ: QCLSHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

0.2784-0.0178 (-6.01%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Q/C Technologies earnings summary

In its most recent report on Nov 18, 2026 (Sep/2026), QCLS posted EPS of $-0.14.

Summary generated from market data by MetaCap's automated system. Methodology

QCLS earnings history

Q/C Technologies reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 18, 2026—$-0.14——
Nov 16, 2026—$-0.14——
Aug 12, 2026—$-0.91——
May 15, 2026—$-0.38——
Nov 19, 2025—$-2.50——
Aug 19, 2025—$-51.10——
May 15, 2025—$-0.36——
Nov 14, 2024—$-107.62——
Aug 19, 2024—$-4.54——
May 15, 2024—$-5.14——
Apr 1, 2024—$-5.14——
Nov 14, 2023—$0.37——
Aug 14, 2023—$-3.22——
May 15, 2023—$-1.20——
Mar 31, 2023—$-11.45——
Nov 10, 2022—$-0.09——

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related